×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Triple-s (3S) Smart Safety Surveillance
Session Chair(s)
Mick Foy
Director of Delivery
Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
This session will inform attendees about the 3S project. Funded by the Bill and Melinda Gates the WHO are working with low and middle income countries with a high disease burden in specific areas that are subject to new treatments to increase their pharmacovigilance capabilities. MHRA are collaborating in the project to ensure regulatory pharmacovigilance capacity is increased to collect, analyse and act on safety data.
Learning Objective : Describe the rationale for 3S; Discuss how industry is key to the success of PV in low and middle income countries; Identify the need for robust regulatory frameworks for PV.
Speaker(s)
Smart Safety Surveillance (TripleS)- Pharmacovigilance Strengthening in Low- to Middle-Income Countries (LMIC)
Raj Long, MEd, MSc
Bill and Melinda Gates Foundation, United Kingdom
Deputy Director, Safety and Pharmacovigilance
Panelist
Andrea Best, DO, MPH
AbbVie, United States
Executive Medical Director
Have an account?